What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Biochemistry
His primary scientific interests are in Internal medicine, Endocrinology, Meibomian gland, Androgen and Hormone.
Many of his studies on Internal medicine apply to Immunoglobulin A as well.
His biological study spans a wide range of topics, including Tears, Lacrimal gland and Secretory component.
His Meibomian gland research is multidisciplinary, relying on both Meibomian gland dysfunction, Fatty acid, Pathology and Cornea, Dry Eye Syndromes.
His Androgen research incorporates elements of Immunology, Castration and Complete androgen insensitivity syndrome.
The study incorporates disciplines such as Disease and Dexamethasone in addition to Hormone.
His most cited work include:
- Prevalence of dry eye syndrome among US women. (890 citations)
- Impact of Dry Eye Syndrome on Vision-Related Quality of Life (533 citations)
- The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland (507 citations)
What are the main themes of his work throughout his whole career to date?
David A. Sullivan mainly focuses on Internal medicine, Endocrinology, Meibomian gland, Lacrimal gland and Androgen.
His Internal medicine study combines topics in areas such as Immunoglobulin A and Dry Eye Syndromes.
His study looks at the relationship between Endocrinology and topics such as Gene expression, which overlap with Regulation of gene expression.
His Meibomian gland research integrates issues from Conjunctiva, Pathology, Meibomian gland dysfunction, Cell biology and Pharmacology.
His Lacrimal gland study also includes
- Lacrimal apparatus together with Exocrine gland,
- Immune system that connect with fields like Antibody.
His research is interdisciplinary, bridging the disciplines of Tear secretion and Androgen.
He most often published in these fields:
- Internal medicine (55.90%)
- Endocrinology (54.66%)
- Meibomian gland (33.23%)
What were the highlights of his more recent work (between 2016-2021)?
- Meibomian gland (33.23%)
- Gene expression (16.15%)
- Lacrimal gland (31.06%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Meibomian gland, Gene expression, Lacrimal gland, Endocrinology and Internal medicine.
The concepts of his Meibomian gland study are interwoven with issues in In vitro, Lysosome, Molecular biology, Toxicity and Pharmacology.
His Gene expression research includes elements of Proinflammatory cytokine, Immune system and Cell biology.
Within one scientific family, David A. Sullivan focuses on topics pertaining to Nod under Lacrimal gland, and may sometimes address concerns connected to Autoimmunity and Immunology.
His work on Hormone and Human growth hormone is typically connected to Aromatase inhibition and Aromatase deficiency as part of general Endocrinology study, connecting several disciplines of science.
The study of Internal medicine is intertwined with the study of Intraocular pressure in a number of ways.
Between 2016 and 2021, his most popular works were:
- TFOS DEWS II pathophysiology report (436 citations)
- TFOS DEWS II Report Executive Summary (211 citations)
- TFOS DEWS II Sex, Gender, and Hormones Report (115 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Biochemistry
His primary areas of study are Meibomian gland, Conjunctiva, Dermatology, Lacrimal gland and Pharmacology.
While working on this project, David A. Sullivan studies both Meibomian gland and Acinus.
His Conjunctiva research incorporates themes from Molecular biology, Cell culture, Human cell and Cornea.
The Dermatology study combines topics in areas such as Metaplasia, Rheumatoid arthritis, Outpatient clinic and SSS*.
His Lacrimal gland research is multidisciplinary, incorporating perspectives in Autoimmune disease, NOD mice and Chemokine, Immune system, Immunology.
His study in Pharmacology is interdisciplinary in nature, drawing from both Protein kinase B and Glaucoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
